FDA 483 - GLOBAL FERTILITY & GENETICS - October 19, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of GLOBAL FERTILITY & GENETICS in New York, NY, a reproductive human tissue establishment, revealed significant deficiencies in their donor eligibility determination and screening processes. The firm failed to ensure donors were eligible based on complete screening and testing, lacked detailed screening procedures for various infectious diseases, and maintained inaccurate and illegible donor records. Additionally, donor records improperly included identifying information for anonymous donors.
ID · 07c9a2d7-a71a-4585-a48a-6f73e729b5e1